Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis (2021)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.15252/emmm.202113929

PubMed Identifier: 34378323

Publication URI: http://europepmc.org/abstract/MED/34378323

Type: Journal Article/Review

Parent Publication: EMBO Molecular Medicine

Issue: 9

ISSN: 1757-4676